A 7 gene expression score predicts for radiation response in cancer cervix
Open Access
- 15 October 2009
- journal article
- Published by Springer Nature in BMC Cancer
- Vol. 9 (1) , 365
Abstract
Cervical cancer is the most common cancer among Indian women. The current recommendations are to treat the stage IIB, IIIA, IIIB and IVA with radical radiotherapy and weekly cisplatin based chemotherapy. However, Radiotherapy alone can help cure more than 60% of stage IIB and up to 40% of stage IIIB patients.Keywords
This publication has 36 references indexed in Scilit:
- Gene expression profiling for the prediction of lymph node metastasis in patients with cervical cancerCancer Science, 2007
- Molecular profiling of cervical cancer progressionBritish Journal of Cancer, 2007
- Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: Identification of candidate amplified and overexpressed genesGenes, Chromosomes and Cancer, 2007
- Application of Bayesian Modeling of Autologous Antibody Responses against Ovarian Tumor-Associated Antigens to Cancer DetectionCancer Research, 2006
- Gene expression levels assessed by oligonucleotide microarray analysis and quantitative real-time RT-PCR – how well do they correlate?BMC Genomics, 2005
- Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processesJournal of Leukocyte Biology, 2005
- Global Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2005
- A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast CancerNew England Journal of Medicine, 2004
- Identification and characterization of the novel centrosome-associated protein CCCAPGene, 2003
- The Stromal Proteinase MMP3/Stromelysin-1 Promotes Mammary CarcinogenesisCell, 1999